NCT03589703

Brief Summary

Almost one-third (30%) of persons 60 years and older suffer from cLBP and cause a significant negative impact on individuals and society in the U.S. The goal of managing cLBP is decreased pain and disability.To accomplish this, cLBP sufferers often use analgesics including opioids to decrease pain and facilitate activity, but the side effects caused by these medications are problematic. A better pain management strategy clearly needs to be developed. The investigators propose to test auricular point acupressure (APA), a non-invasive, easily administered, patient-controlled, and non-pharmacological strategy, to provide rapid, safe, and an innovative solution for chronic low back pain (cLBP) in older adults. APA involves an acupuncture-like stimulation of the ear without needles. With APA, small seeds are taped to specific ear points. The patient is taught to apply pressure to the seeds, with the thumb and index finger, three times a day (morning, noon, and evening) for three minutes each session to achieve pain relief. The investigators have developed a detailed APA protocol to teach health-care providers without experience in acupuncture and traditional Chinese Medicine that investigators can learn about APA in brief educational seminars as a treatment including the systematic identification of ear points (called auricular diagnosis). The investigators teach methods that enable patients to continue using APA to self-manage participants' pain. Brain imaging studies in acupuncture indicate that acupuncture can restore normal functional connectivity related to pain reduction. Studies suggest that stimulation of ear points (1) excites the somatotopic reflex system in the brain and that pathological brain patterns are electrically reset to stop the unwanted activation of spinal pain pathways, explaining the possible immediate pain relief that patients feel after APA and (2) cause a broad spectrum of systemic effects, such as vasodilation, by releasing endorphin to elicit short-term analgesic effects or neuropeptide-induced anti-inflammatory cytokines, which may explain long-term effects. The Ecological Momentary Assessment (EMA) smart phone app will be used to collect real-time cLBP outcomes and adherence to APA practice. Treatment and nonspecific psychological placebo effects will be measured via questionnaires for all participants. Neuro-transmitters is measured by inflammatory biomarkers. Blood samples will be collected for serum collection and a multiplex bead-based immunofluorescence assay performed to check for serum levels. Mini-Mental State Examination will be used to screen for cognitive function, also HRQoL, satisfaction, treatment beliefs and expectations, sleep, relaxation effects, catastrophizing and fear/avoidance, and placebo effects will be measured.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
272

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 18, 2018

Completed
8 months until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2022

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

April 24, 2024

Completed
Last Updated

April 24, 2024

Status Verified

April 1, 2024

Enrollment Period

3.8 years

First QC Date

May 22, 2018

Results QC Date

February 23, 2024

Last Update Submit

April 22, 2024

Conditions

Keywords

Chronic Low Back PaincLBPpainacupressure

Outcome Measures

Primary Outcomes (6)

  • Pain Intensity as Assessed by the Numeric Rating Scale (NRS)

    Pain intensity as assessed by the NRS for worst pain in the past 7 days using a 0-10 scale (0 = "no pain" and 10 = "worst pain imaginable")

    Baseline

  • Pain Intensity as Assessed by the Numeric Rating Scale (NRS)

    Pain intensity as assessed by the NRS for worst pain in the past 7 days using a 0-10 scale (0 = "no pain" and 10 = "worst pain imaginable")

    1 month post completion of the treatment (2 months after baseline)

  • Pain Interference as Assessed by the Brief Pain Inventory-short Form Pain Interference Subscale

    Pain interference is assessed by the Brief Pain Inventory pain interference subscale, which uses a 0-10 scale (0 = "does not interfere" and 10 = "completely interferes").

    Baseline

  • Pain Interference as Assessed by the Brief Pain Inventory-short Form Pain Interference Subscale

    Pain interference is assessed by the Brief Pain Inventory pain interference subscale, which uses a 0-10 scale (0 = "does not interfere" and 10 = "completely interferes").

    1 month post completion of the treatment (2 months after baseline)

  • Physical Function as Assessed by the Roland Morris Disability Questionnaire (RMDQ)

    The Roland Morris Disability Questionnaire (RMDQ), 24-item measure, is used to assess the impact of back pain on their daily functioning. The score ranges from 0 (no disability) to 24 (maximum disability).

    Baseline

  • Physical Function as Assessed by the Roland Morris Disability Questionnaire (RMDQ)

    The Roland Morris Disability Questionnaire (RMDQ), 24-item measure, is used to assess the impact of back pain on their daily functioning. The score ranges from 0 (no disability) to 24 (maximum disability).

    1 month post completion of the treatment (2 months after baseline)

Secondary Outcomes (18)

  • Number of Participants Who Use Opioids

    Baseline

  • Number of Participants Who Use Opioids

    1 month post completion of the treatment (2 months after baseline)

  • APA Treatment Satisfaction as Assessed by Satisfaction Survey

    immediately post intervention (1 month after baseline)

  • APA Treatment Satisfaction as Assessed by Satisfaction Survey

    1 month post completion of the treatment (2 months after baseline)

  • Quality of Life as Assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS-29) - Anxiety

    Baseline

  • +13 more secondary outcomes

Study Arms (3)

T-APA

ACTIVE COMPARATOR

Patients with active points related to cLBP. Will receive acupressure within the two zones for cLBP located on the front and back of the ear and three points known for alleviating stress and pain.

Other: Target ear points related to chronic low back pain (T-APA)

NT-APA

ACTIVE COMPARATOR

The same procedure for APA will be applied but the tapes/seeds will be placed on five different ear points, comprising mouth, stomach, duodenum, internal ear, and tonsil. These points are chosen for the non-target ear points of APA treatment for two reasons. First, they are distinct from the zones of the ear (and the points therein) associated with the lower back, and correspond to body regions in which the participant is usually pain-free. Second, they are equivalent in number to those points used in the APA treatment group.

Other: Non-Target ear Points not related to chronic low back pain (NT-APA)

Enhanced Educational Control Group (CG-2)

OTHER

Participants in the enhanced educational control group will be given the cLBP educational booklet and visit the office weekly for assessment (i.e., blood draws and questionnaires), which is the same schedule as that for the APA groups.

Other: Enhanced Educational Control Group (CG-2)

Interventions

Light touch using vaccaria seeds on specific points of the ear.

T-APA

Light touch using vaccaria seeds on different points of the ear (compared to the APA group).

NT-APA

No contact with the subject. Participants in the enhanced educational control group will be given the cLBP educational booklet.

Enhanced Educational Control Group (CG-2)

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 60 years or older
  • Able to read and write English
  • cLBP that has persisted at least 3 months and has pain on at least half of the days for the previous 6 months
  • Average intensity of pain ≥ 4 on a 11-point numerical pain scale in the previous week
  • Have intact cognition (Mini-Mental State Examination (MMSE) \> 24)
  • Willing to commit to up to 13-17 months as a study participant, depending on which group the participant is placed in
  • Able to apply pressure to the seeds with tapes on their ears

You may not qualify if:

  • Malignant or autoimmune diseases (e.g., rheumatoid arthritis), in which the pain from the disease cannot be separated from the low back pain by the participant
  • Known acute compression fractures caused by osteoporosis, spinal stenosis, spondylolysis, or spondylolisthesis because these conditions may confound treatment effects or the interpretation of results
  • Sciatica with leg pain greater than back pain
  • Allergy to the tape
  • Use of some types of hearing aids (size may obstruct the placement of seeds)
  • Pain in other parts of the body that is more severe than the cLBP and which occurs daily or almost every day with at least moderate intensity or acute pain
  • Neurological disorders that could interfere with pain reporting or confound performance on the other outcomes, cerebral tumor, Alzheimer's disease (or other cognitive illnesses), prior stroke, or multiple sclerosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Johns Hopkins Hospital

Baltimore, Maryland, 21205, United States

Location

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

Related Publications (3)

  • Zhang J, Castelli G, Shen A, Li J, Kawi J, Wu H, Christo P, Campbell CM, Thrul J, Johnson CM, Lukkahatai N. Effectiveness of acupressure at different ear acupoints on Insomnia: A secondary analysis of a randomized controlled trial. Sleep Med X. 2025 Oct 15;10:100158. doi: 10.1016/j.sleepx.2025.100158. eCollection 2025 Dec 15.

  • Kawi J, Yeh CH, Lukkahatai N, Wu H, Morone NE, Glick R, Schlenk EA, Campbell C, Thrul J, Huang X, Wang H, Jia HM, Christo P, Johnson C. Auricular point acupressure for older adults with chronic low back pain: a randomized controlled trial. Pain Med. 2025 Sep 1;26(9):515-526. doi: 10.1093/pm/pnaf035.

  • Yeh CH, Li C, Glick R, Schlenk EA, Albers K, Suen LK, Lukkahatai N, Salen N, Pandiri S, Ma W, Perrin N, Morone NE, Christo PJ. A prospective randomized controlled study of auricular point acupressure to manage chronic low back pain in older adults: study protocol. Trials. 2020 Jan 20;21(1):99. doi: 10.1186/s13063-019-4016-x.

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Nada Lukkahatai, PhD, MSN, RN, CNE, FAAN
Organization
Johns Hopkins University

Study Officials

  • Constance Johnson, PhD, MS, RN

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR
  • Nada Lukkahatai, PhD, MSN, RN

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 22, 2018

First Posted

July 18, 2018

Study Start

March 1, 2019

Primary Completion

December 6, 2022

Study Completion

January 1, 2023

Last Updated

April 24, 2024

Results First Posted

April 24, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations